Bioelectronics Corp Stock Analysis
| BIEL Stock | USD 0.0003 0.00 0.00% |
Bioelectronics Corp is overvalued with Real Value of 2.74E-4 and Hype Value of 4.06E-4. The main objective of Bioelectronics Corp pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bioelectronics Corp is worth, separate from its market price. There are two main types of Bioelectronics Corp's stock analysis: fundamental analysis and technical analysis.
The Bioelectronics Corp pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Bioelectronics |
Bioelectronics Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for Bioelectronics Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioelectronics Corp please contact Kelly Whelan at 301 874 4890 or go to https://www.bielcorp.com.Bioelectronics Corp Investment Alerts
| Bioelectronics Corp is way too risky over 90 days horizon | |
| Bioelectronics Corp has some characteristics of a very speculative penny stock | |
| Bioelectronics Corp appears to be risky and price may revert if volatility continues | |
| Bioelectronics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (289.82 K) with profit before overhead, payroll, taxes, and interest of 795.53 K. | |
| Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations. |
Bioelectronics Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioelectronics Corp's market, we take the total number of its shares issued and multiply it by Bioelectronics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Bioelectronics Profitablity
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.Technical Drivers
As of the 14th of December 2024, Bioelectronics Corp shows the Risk Adjusted Performance of 0.0603, downside deviation of 32.68, and Mean Deviation of 10.77. Bioelectronics Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bioelectronics Corp jensen alpha, as well as the relationship between the potential upside and skewness to decide if Bioelectronics Corp is priced correctly, providing market reflects its regular price of 3.0E-4 per share. As Bioelectronics Corp appears to be a penny stock we also recommend to validate its total risk alpha numbers.Bioelectronics Corp Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bioelectronics Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bioelectronics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bioelectronics Corp Outstanding Bonds
Bioelectronics Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioelectronics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioelectronics bonds can be classified according to their maturity, which is the date when Bioelectronics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View |
Bioelectronics Corp Predictive Daily Indicators
Bioelectronics Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioelectronics Corp pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2.7 M | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 3.0E-4 | |||
| Day Typical Price | 3.0E-4 | |||
| Price Action Indicator | 1.0E-4 |
Bioelectronics Corp Forecast Models
Bioelectronics Corp's time-series forecasting models are one of many Bioelectronics Corp's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioelectronics Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bioelectronics Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bioelectronics Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioelectronics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bioelectronics Corp. By using and applying Bioelectronics Pink Sheet analysis, traders can create a robust methodology for identifying Bioelectronics entry and exit points for their positions.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bioelectronics Corp to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.